🏅 FDA Orphan Designation

Normocarb HF

bicarbonate infusate

Manufacturer: Dialysis Solutions, Inc.

Indicated for:

Late-onset retinal degenerationOrphanCongenital sucrase-isomaltase deficiencyErythrocyte galactose epimerase deficiency

FDA-Approved Indications (3)

Late-onset retinal degenerationOrphan Designation

Use as a replacement solution in Continuous Renal Replacement Therapy (CRRT) to replace water and to correct electrolytes and acid-base imbalances in adults and children

Congenital sucrase-isomaltase deficiency

Use as a replacement solution in Continuous Renal Replacement Therapy (CRRT) to replace water and to correct electrolytes and acid-base imbalances

Population: adults and children

Erythrocyte galactose epimerase deficiency

Use as a replacement solution in Continuous Renal Replacement Therapy (CRRT) to replace water and to correct electrolytes and acid-base imbalances

Population: adults and children

Indications & Usage

Use as a replacement solution in Continuous Renal Replacement Therapy (CRRT) to replace water and to correct electrolytes and acid-base imbalances in adults and children

💙 Support Programs

View all →

Normocarb HF

Dialysis Solutions, Inc.

Normocarb HF

Dialysis Solutions, Inc.

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.